IBS Inc. leverages technology to develop drug testing and biosensor solutions that aim to improve quality of life. Self-described as pioneering pain-free solutions.

IBS Inc.

Abbott develops and delivers health care technologies and products. The company focuses on various sectors of health care, including diagnostics and nutrition. Self-described as a provider of life-changing solutions.

Abbott

Bosch develops and provides technology and services in multiple sectors including mobility, industry, and home appliances. The company focuses on innovations addressing major challenges like energy efficiency and automated driving.

Bosch

Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Cue Health Inc.

IBS, Incorporated is a full service distributor of high quality products for use in maintenance and repair operations. Our professional sales force, personalized service, specialty labor saving products, and custom inventory management programs distinguish IBS as a leader in the maintenance supply arena.

IBS, Inc.

We've got a new website. Check it out!
industrialbolt.com

Metric
Company Name	IBS Inc.	Abbott	Bosch	Cue Health Inc.
Symbol				HLTH
MSH ID	INC:IBS	COM:ABBOTT	COM:BOSCH	COM:CUEHEALTH
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Healthcare & Health Services	Healthcare & Health Services	Technology	Healthcare
Industry	Medical Technology	Medical Devices and Diagnostics	Manufacturing	Medical - Healthcare Information Services
Country	US	US	DE	US
Stage
Employee Count	19	10.00K		726
Website	ibs.inc	abbott.com	bosch.com	cuehealth.com
LinkedIn				cuehealthinc
Founders

Metric
Market Cap		6.90M
Enterprise Value
Monthly Web Traffic	873.36K
Web Traffic Growth	-0.14
Valuation
Raised Capital

Metric
Revenue				70.94M
Revenue (LTM)
Revenue (NTM)
Gross Profit				-56.16M
EBITDA				-240.44M
Operating Income				-296.71M
Net Income				-373.46M
EPS				-2.44
Diluted EPS				-2.44
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				-0.94
Operating Profit Margin				-4.74
EBITDA Margin				-3.39
Net Profit Margin				-5.67
Return on Equity				-0.96
Return on Assets				-1.09
Return on Capital Employed				-1.05

INC:IBS

IBS Inc.

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				-0.14
P/B Ratio				0.09
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				0.46
EV Multiple				-0.02

Metric
Days Sales Outstanding				2.49
Days Payables Outstanding				22.26
Days Inventory Outstanding				48.12
Operating Cycle				50.89
Cash Conversion Cycle				27.73
Asset Turnover				0.19

Metric
Operating Cash Flow				-137.81M
Free Cash Flow				-157.61M
Cash Flow to Debt				-2.87
Operating Cash Flow/Sales				-2.10
Free Cash Flow Yield				-5.33

Metric
Cash & Equivalents				81.69M
Accounts Receivable				17.72M
Inventory				14.04M
Goodwill
Debt to Capitalization				0.16
Debt to Assets				0.10
Current Ratio				3.29
Quick Ratio				1.92

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.28
R&D to Revenue				0.90
SG&A to Revenue				0.34